Almost 100 per cent shareholders have approved "the scheme of arrangement between Cadila Healthcare Ltd and Zydus Healthcare Ltd and their respective shareholders and creditors," Cadila Healthcare said in a BSE filing today.
The voting results were the outcome of a National Company Law Tribunal (NCLT) convened meeting of the shareholders of the company held on March 30, 2017, it added.
Pharma firm Cadila Healthcare is a listed entity of the Zydus Group.